Not yet recruitingPriority 4 · Lower priorityNCT07538960

Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.

Plain-language summary

This trial is studying a new treatment for people with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.

Who can join (key eligibility)

Age 18 Years or older
See full trial listing for complete eligibility

Final eligibility is determined by the trial team. This list is a starting point only.

What's being tested

Drugs / treatments
Treatment length: Ask the trial team for details
Visit frequency: Ask the trial team for details

TrialCompass — Clinical Trial Summary

Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.

NCT07538960

Phase: | Status: Not yet recruiting | Priority: Lower

Plain-language summary

Who can join

Age 18 Years or older
See full trial listing for complete eligibility

What's being tested

Drugs / treatments:

Treatment length: Ask the trial team for details

Visit frequency: Ask the trial team for details

Trial design

Non-randomized, blind

Enrollment target: 350 patients

Primary endpoint: Characterize the epidemiology; Characterize the therapeutic management

Ages: 18 Years to —

Start date: 2026-05 | Est. completion: 2027-05

Locations

0 US sites · 1 total

Contact

Daniel Barquero-Orias, Dermatologist | debarque@ccss.sa.cr | +506 83411026

Sponsor: Caja Costarricense de Seguro Social (OTHER_GOV)

View on ClinicalTrials.gov

https://clinicaltrials.gov/study/NCT07538960

Prepared using TrialCompass (trialcompass.com) on June 19, 2026. For informational purposes only. Always discuss with your healthcare team.